{
  "actions": [
    {
      "acted_at": "2020-03-05", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2020-03-05", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6102-116", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "B001275", 
      "district": "8", 
      "name": "Bucshon, Larry", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-03-05", 
      "state": "IN", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2020-03-05", 
  "number": "6102", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s3404-116", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "VALID Act of 2020", 
  "sponsor": {
    "bioguide_id": "D000197", 
    "district": "1", 
    "name": "DeGette, Diana", 
    "state": "CO", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2020-03-05", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Administrative remedies", 
    "Advisory bodies", 
    "Congressional oversight", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Emergency medical services and trauma care", 
    "Federal preemption", 
    "Food and Drug Administration (FDA)", 
    "Government information and archives", 
    "Health", 
    "Health technology, devices, supplies", 
    "Licensing and registrations", 
    "Medical tests and diagnostic methods", 
    "Performance measurement", 
    "User charges and fees"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "VALID Act of 2020", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "VALID Act of 2020", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Verifying Accurate Leading-edge IVCT Development Act of 2020", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Verifying Accurate Leading-edge IVCT Development Act of 2020", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "VALID Act of 2020", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2020-07-13T18:41:51Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr6102.xml"
}